Why Your Lyme Treatment
Keeps Failing

The kill-everything model of Lyme treatment creates predictable damage. Here is why and what to do instead.

By Brehan Crawford, MAcOM, LAc

The cycle nobody told you about

If I described your treatment experience back to you, it would probably sound something like this: You start a new protocol  antimicrobials, antibiotics, herbal or pharmaceutical, doesn't matter. You feel worse for a while and get told that's a good sign. Then you feel a little better. Then it stops working. You add something else, or switch entirely. You flare. You crash. You lose months. You try again.

Kill. Flare. Crash. Add more. Get sensitive. Quit. Relapse. Repeat. That is the loop. And if you've been living inside it, I want you to know — it isn't because you're doing something wrong. It's because the model itself is broken.

This is Part 2 of a five-part series summarizing the Lyme Remission Map masterclass. In this article, I'm going to explain why most Lyme treatments produce the same disappointing results — and what a different approach actually looks like.

19th-century thinking in a 21st-century body

The kill-only approach to infection isn't wrong because it's aggressive. It's wrong because it's incomplete. It's rooted in a model of disease from the 1800s — Pasteur's germ theory — that says: find the bug, kill the bug, problem solved. That model works beautifully for acute infection. A sinus infection. A UTI. Strep throat. You take your course of antibiotics, the pathogen dies, you heal.

But chronic tick-borne illness doesn't behave like a sinus infection. By the time most patients reach my clinic, the original infection has become a complex, multi-system problem. You're not just dealing with Borrelia anymore. You're dealing with what Borrelia did to the terrain it lived in — and what the treatments did to everything else.

The three failure patterns I see most often

After fifteen-plus years of working with chronic Lyme patients, I can usually predict what's gone wrong before someone finishes their intake. It almost always falls into one of three categories:

None of these are caused by the tick bite alone. They're caused — or at least significantly worsened — by treatment strategies that ignore the ecosystem the infection is living in.

Stop carpet-bombing. Start gardening.

Here's a metaphor I use constantly, because it works: Imagine your gut is a forest. You've got beneficial species, opportunistic species, neutral bystanders, and yes — some genuine pathogens. A healthy forest keeps everything in check through competition, diversity, and terrain conditions.

Now imagine carpet-bombing that forest. You kill some of the target organisms. You also kill the beneficial species holding them in check. You sterilize the soil. And then — because nature doesn't tolerate a vacuum — the first things to grow back are the weeds. Candida. Opportunistic bacteria. Biofilm-forming organisms. The very things you were trying to eliminate now have less competition than ever.

A gardener doesn't work this way. A gardener changes the soil. Adjusts the pH. Adds compost. Creates conditions where the plants you want can outcompete the ones you don't. It's slower. It's less dramatic. And it's the only approach that produces lasting results in chronic illness.

In practical terms, that looks like warm, cooked plant fibers — not raw salads and cold smoothies (which most Lyme patients can't digest anyway). It looks like ginger tea, aromatic herbs like rosemary and thyme in your cooking, and building internal warmth before you introduce any antimicrobial strategy.

Why formulas outperform single compounds

In the integrative Lyme world, you'll hear a lot about individual antimicrobial herbs. Berberine. Cat's claw. Japanese knotweed. These herbs do have antimicrobial properties — I'm not disputing that. What I'm disputing is the idea that you can use them the same way you'd use an antibiotic: isolate the compound, ramp up the dose, and aim for a kill.

Traditional Chinese Medicine figured something out centuries ago that modern pharmacology is just starting to acknowledge: plant formulas work because of synergy. Berberine alone at high doses is cold and harsh on the gut. Berberine combined with Atractylodes — which strengthens digestion and dries dampness — combined with Poria — which supports fluid metabolism and calms the nervous system — produces a different effect entirely. The formula addresses the terrain while managing the pathogen.

This is the principle behind Chorus Capsules (Gut Harmony) — not a kill formula, but a terrain formula. Its job is to create the internal conditions where your gut ecology can recover and your immune system can start doing its actual job again.

Kelly: Three years of rotating antibiotics

Clinical details shared with patient permission. Individual outcomes depend on many factors and are not guaranteed.

The 7-day treatment audit

Before you add anything new, honestly assess what your current protocol is doing to your terrain. For one week, track these questions each evening:

If three or more answers point in the wrong direction, that's meaningful clinical data. We walk through exactly how to interpret these patterns inside the Gut Brain Synchrony community.

The problem isn't your body.
It's the plan.

The full Lyme Remission Map masterclass covers nine modules of terrain science, clinical case studies, and practical recovery strategies. Watch it free inside the Gut Brain Synchrony community. Up next in this series: The Three Components — terrain temperature, biofilm balance, and gas pressure.

1. Ramirez J, Guarner F, Bustos Fernandez L, et al. (2020). Antibiotics as major disruptors of gut microbiota. Frontiers in Cellular and Infection Microbiology, 10, 572912. doi:10.3389/fcimb.2020.572912
2. Maier L, Pruteanu M, Kuhn M, et al. (2018). Extensive impact of non-antibiotic drugs on human gut bacteria. Nature, 555(7698), 623-628. doi:10.1038/nature25979
3. Morrissette M, Pitt N, Bhatt P, et al. (2020). A distinct microbiome signature in posttreatment Lyme disease patients. mBio, 11(5), e02310-20. doi:10.1128/mBio.02310-20